Cited 0 times in Scipus Cited Count

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer.

DC Field Value Language
dc.contributor.authorHong, WS-
dc.contributor.authorJeon, JY-
dc.contributor.authorKang, SY-
dc.contributor.authorJung, YS-
dc.contributor.authorKim, JY-
dc.contributor.authorAhn, MS-
dc.contributor.authorKang, DK-
dc.contributor.authorKim, TH-
dc.contributor.authorYim, HE-
dc.contributor.authorAn, YS-
dc.contributor.authorPark, RW-
dc.contributor.authorKim, KS-
dc.date.accessioned2014-05-27T04:53:26Z-
dc.date.available2014-05-27T04:53:26Z-
dc.date.issued2013-
dc.identifier.issn2233-7903-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/10182-
dc.description.abstractPURPOSE: Neoadjuvant chemotherapy is the standard treatment for patients with locally advanced breast cancer and is increasingly considered for patients with operable disease. Recently, as many clinical trials have demonstrated favorable outcomes of anthracycline-taxane based regimen, this approach has been widely used in the neoadjuvant setting.
METHODS: We compared women who received adriamycine and docetaxel (AD) with adriamycin, cyclophosphamide followed by paclitaxel (AC-T) as neoadjuvant chemotherapy. The AD group was scheduled for six cycles of AD (50 mg/m(2) and 75 mg/m(2), respectively) at a 3-week interval. The AC-T group was scheduled for four cycles of adriamycin and cyclophosphamide (50 mg/m(2) and 500 mg/m(2), respectively) followed by four cycles of paclitaxel (175 mg/m(2)) at a 3-week interval.
RESULTS: The responses of chemotherapy were equivalent (overall response rate [AD, 75.7% vs. AC-T, 80.9%; P = 0.566], pathologic complete response [pCR] rate [breast and axilla: AD, 10.8% vs. AC-T, 12.8%; P = 1.000; breast only: AD, 18.9% vs. AC-T, 14.9%, P = 0.623], breast conserving surgery rate [P = 0.487], and breast conserving surgery conversion rate [P = 0.562]). The pCR rate in the breast was higher in the human epidermal growth factor receptor 2 (HER2) positive cases (HER2 positive 33.3% vs. negative 10%, P = 0.002). Although nonhematologic toxicities were comparable, hematologic toxicities were more severe in the AD group. Most women in the AD group suffered from grade 3/4 neutropenia (P < 0.001) and neutropenic fever (P < 0.001).
CONCLUSION: Tumor responses were not different in various variables between the two groups. However, AC-T was a more tolerable regimen than AD in patients with breast cancer receiving neoadjuvant chemotherapy.
en
dc.formatapplication/pdf-
dc.language.isoen-
dc.titleComparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer.-
dc.typeArticle-
dc.identifier.pmid23833754-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699689/-
dc.subject.keywordBreast neoplasms-
dc.subject.keywordNeoadjuvant therapy-
dc.contributor.affiliatedAuthor전, 자영-
dc.contributor.affiliatedAuthor강, 석윤-
dc.contributor.affiliatedAuthor정, 용식-
dc.contributor.affiliatedAuthor김, 지영-
dc.contributor.affiliatedAuthor안, 미선-
dc.contributor.affiliatedAuthor강, 두경-
dc.contributor.affiliatedAuthor김, 태희-
dc.contributor.affiliatedAuthor임, 현이-
dc.contributor.affiliatedAuthor안, 영실-
dc.contributor.affiliatedAuthor박, 래웅-
dc.contributor.affiliatedAuthor김, 구상-
dc.type.localJournal Papers-
dc.identifier.doi10.4174/jkss.2013.85.1.7-
dc.citation.titleJournal of the Korean Surgical Society-
dc.citation.volume85-
dc.citation.number1-
dc.citation.date2013-
dc.citation.startPage7-
dc.citation.endPage14-
dc.identifier.bibliographicCitationJournal of the Korean Surgical Society, 85(1). : 7-14, 2013-
dc.identifier.eissn2093-0488-
dc.relation.journalidJ022337903-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Endocrinology & Metabolism
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Radiology
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Journal Papers > School of Medicine / Graduate School of Medicine > Nuclear Medicine & Molecular Imaging
Journal Papers > School of Medicine / Graduate School of Medicine > Biomedical Informatics
Files in This Item:
23833754.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse